Application for registration of Kangzhi pharmaceutical paracetamol oral suspension is accepted

In the afternoon of February 21, Kangzhi pharmaceutical announced that on February 19, the company received the notice of acceptance of drug registration application from the State Food and Drug Administration on 6 kinds of chemicals "paracetamol oral suspension" Acetaminophen oral suspension is a kind of over-the-counter medicine for antipyretic and analgesic It is commonly used in the treatment of cold, fever, headache and other symptoms It has good effect and quick effect It is one of the main kinds of antipyretic and analgesic drugs Kangzhi pharmaceutical said that at present, there are production approval documents in the drug market, and the paracetamol oral suspension declared by the company this time belongs to the imitation preparation If the application for acetaminophen oral suspension is approved, it must be approved by the State Food and drug administration After the approval, the clinical trial will be conducted according to the requirements of the approval results After the clinical trial is successful, the production approval will be applied according to the procedures Whether the application can be reviewed and approved by the State Food and drug administration is uncertain It is expected that this event will not affect the company's performance in 2014.